We are excited to have you join us as an abstract presenter during The Liver Meeting Digital Experience™ (TLMdX). This year, AASLD will work with Freeman to offer a bold, captivating digital event using the platform OnlineEvent®Pro. All presentations will be recorded prior to the event to allow you the unique opportunity to engage with the audience while your presentation is streaming using the platform's interactive text chat and Q&A features.
As you prepare to present at TLMdX™, please remember to:
If you cannot present during TLMdX, please inform AASLD staff at your earliest convenience.
The Speaker Center is your one-stop-shop to view your confirmed faculty engagements and session information, and to plan your meeting schedule.
To help you develop your presentation, please find a list of required slide content required below.
Download the Virtual Presenter Toolkit for tips and tricks to ensure your PowerPoint and recording are the best they can be.
Required Slide Content:
All attendees, members of the media, companies, institutions, organizations, universities, investment advisors, and all other individuals, are required to abide by AASLD’s Abstract Embargo Policy governing The Liver Meeting®. An embargo means that information from any abstract or presentation is confidential and may not be announced, publicized, or distributed before the embargo date and time except as permitted by this policy.
Accepted abstracts are made available to the public on the AASLD website in early October and are published in the October supplement of HEPATOLOGY. Late-breaking abstracts will be available on the AASLD website and the online planner of The Liver Meeting Digital Experience™ November 13 at 10:00 am ET and are published in the December issue of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website.
Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until 8:00 am local time of the meeting location on the first day of the meeting.
The purpose of the embargo policy is to protect the scientific integrity of the abstract submissions presented at TLMdX. Violation of the embargo policy by release of information contained in any abstract prior to its embargoed date and time may result in the individual, as well as the employer/affiliated company, institution, organization, etc., being removed from The Liver Meeting®, with a potential two-year ban on returning. Authors are responsible for notifying financial and other sponsors about this policy.
View the Embargo Policy for more information.